Homburger acted as legal advisor to UBS Switzerland in its role as mandated lead arranger, sole underwriter, bookrunner, agent, security agent, and original lender for the financing of United Grinding Group’s acquisition of GF
Niederer Kraft Frey (NKF) acted as legal advisor to Invision and other shareholders of Parkresort Rheinfelden in the sale of the wellness division of Parkresort Rheinfelden to RS Properties. The acquisition ensures that the wellness
Law firm Advoro has strengthened its legal advisory capabilities by appointing Raphael Wyss as a new partner in its Zurich office. Wyss, an experienced attorney with deep expertise in life sciences, healthcare, and regulatory matters,
Schellenberg Wittmer acted as legal advisor to Made 2 Design, a holding company controlled by Swiss investors, in its strategic investment in the luxury skiwear and lifestyle brand Ogier. Ogier, established in 1948, began as a retailer
Niederer Kraft Frey (NKF) acted as legal advisor to the shareholders of BAC Pool Systems in the sale of 100% of BAC’s share capital to Fluidra. BAC Pool Systems, a German-Swiss company, is a renowned
BGPartner acted as legal advisor to Lafayette Mittelstand Capital on its acquisition of a majority stake in Diametal Group, a global leader in high-precision cutting tools, super abrasives, and wear parts. The transaction, which became
Baker McKenzie has strengthened its tax practice in Switzerland by welcoming Sylvain Godinet and Raphaël Matthys as Counsels to its Geneva office. The two legal professionals bring a combined 35 years of experience in international
Thurmed group relied on Pestalozzi for legal and tax advice in the sale of Wäscherei Bodensee AG to ELIS.The transaction involved the sale of all shares of Wäscherei Bodensee AG, which operates
Advestra has acted as Swiss legal counsel to the initial purchasers and lenders in connection with the financing of Bain Capital’s acquisition of SO.MA.CI.S. and the subsequent acquisition of AT&
BGPartner has advised OrbiMed and Novo Holdings on Swiss legal matters related to the USD 200 million Series A financing of Windward Bio Group, a Swiss-based clinical-stage drug development company, advised by Homburger. The financing round
